202 related articles for article (PubMed ID: 38369520)
1. Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer.
Adashek JJ; Pandya C; Maragakis NJ; De P; Cohen PR; Kato S; Kurzrock R
BMC Med; 2024 Feb; 22(1):74. PubMed ID: 38369520
[TBL] [Abstract][Full Text] [Related]
2. ErbB4 Mutation that Decreased NRG1-ErbB4 Signaling Involved in the Pathogenesis of Amyotrophic Lateral Sclerosis/Frontotemporal Dementia.
Sun L; Cheng B; Zhou Y; Fan Y; Li W; Qiu Q; Fang Y; Xiao S; Zheng H; Li X
J Alzheimers Dis; 2020; 74(2):535-544. PubMed ID: 32065797
[TBL] [Abstract][Full Text] [Related]
3. Altered immunoreactivity of ErbB4, a causative gene product for ALS19, in the spinal cord of patients with sporadic ALS.
Takahashi Y; Uchino A; Shioya A; Sano T; Matsumoto C; Numata-Uematsu Y; Nagano S; Araki T; Murayama S; Saito Y
Neuropathology; 2019 Aug; 39(4):268-278. PubMed ID: 31124187
[TBL] [Abstract][Full Text] [Related]
4. Parvalbumin interneurons dysfunction is potentially associated with FαMNs decrease and NRG1-ErbB4 signaling inhibition in spinal cord in amyotrophic lateral sclerosis.
Kang Q; Jiang S; Min J; Hu F; Xu R
Aging (Albany NY); 2023 Dec; 15(24):15324-15339. PubMed ID: 38157256
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Role of Neuregulin 1 Type III in SOD1-Linked Amyotrophic Lateral Sclerosis.
Mòdol-Caballero G; García-Lareu B; Verdés S; Ariza L; Sánchez-Brualla I; Brocard F; Bosch A; Navarro X; Herrando-Grabulosa M
Neurotherapeutics; 2020 Jul; 17(3):1048-1060. PubMed ID: 31965551
[TBL] [Abstract][Full Text] [Related]
6. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons.
Lasiene J; Komine O; Fujimori-Tonou N; Powers B; Endo F; Watanabe S; Shijie J; Ravits J; Horner P; Misawa H; Yamanaka K
Acta Neuropathol Commun; 2016 Feb; 4():15. PubMed ID: 26891847
[TBL] [Abstract][Full Text] [Related]
7. Aberrant neuregulin 1 signaling in amyotrophic lateral sclerosis.
Song F; Chiang P; Wang J; Ravits J; Loeb JA
J Neuropathol Exp Neurol; 2012 Feb; 71(2):104-15. PubMed ID: 22249457
[TBL] [Abstract][Full Text] [Related]
8. Decreased circulating ErbB4 ectodomain fragments as a read-out of impaired signaling function in amyotrophic lateral sclerosis.
Lopez-Font I; Sogorb-Esteve A; Javier-Torrent M; Brinkmalm G; Herrando-Grabulosa M; García-Lareu B; Turon-Sans J; Rojas-García R; Lleó A; Saura CA; Zetterberg H; Blennow K; Bosch A; Navarro X; Sáez-Valero J
Neurobiol Dis; 2019 Apr; 124():428-438. PubMed ID: 30594809
[TBL] [Abstract][Full Text] [Related]
9. The neuregulin-I/ErbB signaling system in development and disease.
Britsch S
Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
[TBL] [Abstract][Full Text] [Related]
10. Activation of NRG1-ERBB4 signaling potentiates mesenchymal stem cell-mediated myocardial repairs following myocardial infarction.
Liang X; Ding Y; Zhang Y; Chai YH; He J; Chiu SM; Gao F; Tse HF; Lian Q
Cell Death Dis; 2015 May; 6(5):e1765. PubMed ID: 25996292
[TBL] [Abstract][Full Text] [Related]
11. ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19.
Takahashi Y; Fukuda Y; Yoshimura J; Toyoda A; Kurppa K; Moritoyo H; Belzil VV; Dion PA; Higasa K; Doi K; Ishiura H; Mitsui J; Date H; Ahsan B; Matsukawa T; Ichikawa Y; Moritoyo T; Ikoma M; Hashimoto T; Kimura F; Murayama S; Onodera O; Nishizawa M; Yoshida M; Atsuta N; Sobue G; ; Fifita JA; Williams KL; Blair IP; Nicholson GA; Gonzalez-Perez P; Brown RH; Nomoto M; Elenius K; Rouleau GA; Fujiyama A; Morishita S; Goto J; Tsuji S
Am J Hum Genet; 2013 Nov; 93(5):900-5. PubMed ID: 24119685
[TBL] [Abstract][Full Text] [Related]
12. The role of endothelial autocrine NRG1/ERBB4 signaling in cardiac remodeling.
Dugaucquier L; Feyen E; Mateiu L; Bruyns TAM; De Keulenaer GW; Segers VFM
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H443-H455. PubMed ID: 32618511
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling.
Wandinger SK; Lahortiga I; Jacobs K; Klammer M; Jordan N; Elschenbroich S; Parade M; Jacoby E; Linders JT; Brehmer D; Cools J; Daub H
PLoS One; 2016; 11(1):e0146100. PubMed ID: 26745281
[TBL] [Abstract][Full Text] [Related]
14. Aberrant accumulation of ErbB4 in progressive supranuclear palsy.
Murakami A; Nakamura M; Kaneko S; Lin WL; Dickson DW; Kusaka H
Neuropathol Appl Neurobiol; 2018 Oct; 44(6):563-573. PubMed ID: 29319907
[TBL] [Abstract][Full Text] [Related]
15. Interneuronal DISC1 regulates NRG1-ErbB4 signalling and excitatory-inhibitory synapse formation in the mature cortex.
Seshadri S; Faust T; Ishizuka K; Delevich K; Chung Y; Kim SH; Cowles M; Niwa M; Jaaro-Peled H; Tomoda T; Lai C; Anton ES; Li B; Sawa A
Nat Commun; 2015 Dec; 6():10118. PubMed ID: 26656849
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of neuregulin 1-ErbB4 signaling in parvalbumin interneurons in the rat brain may contribute to the antidepressant properties of ketamine.
Wang N; Zhang GF; Liu XY; Sun HL; Wang XM; Qiu LL; Yang C; Yang JJ
J Mol Neurosci; 2014; 54(2):211-8. PubMed ID: 24633675
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of novel ERBB4 variant associated with sporadic amyotrophic lateral sclerosis (ALS).
Kwon Y; Kang M; Jeon YM; Lee S; Lee HW; Park JS; Kim HJ
J Neurol Sci; 2024 Feb; 457():122885. PubMed ID: 38278691
[TBL] [Abstract][Full Text] [Related]
18. Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration.
Haskins JW; Nguyen DX; Stern DF
Sci Signal; 2014 Dec; 7(355):ra116. PubMed ID: 25492965
[TBL] [Abstract][Full Text] [Related]
19. Increased Seizure Susceptibility for Rats Subject to Early Life Hypoxia Might Be Associated with Brain Dysfunction of NRG1-ErbB4 Signaling in Parvalbumin Interneurons.
Liang D; Fan F; Ding W; Fang Y; Hu L; Lei B; Zhang M
Mol Neurobiol; 2020 Dec; 57(12):5276-5285. PubMed ID: 32870492
[TBL] [Abstract][Full Text] [Related]
20. Neuroinflammation-Induced Downregulation of Hippocampacal Neuregulin 1-ErbB4 Signaling in the Parvalbumin Interneurons Might Contribute to Cognitive Impairment in a Mouse Model of Sepsis-Associated Encephalopathy.
Gao R; Ji MH; Gao DP; Yang RH; Zhang SG; Yang JJ; Shen JC
Inflammation; 2017 Apr; 40(2):387-400. PubMed ID: 27913953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
